Germany Orders 1.7 Million Doses
Of Glaxo's Relenza Flu Drug

LONDON -- The German government placed an order for 1.7 million doses of GlaxoSmithKline PLC's influenza drug Relenza, a company spokesman said Thursday.

The spokesman declined to provide financial details of the contract.

The government is stockpiling the drug, which Australian biotechnology company Biota Holdings Ltd. licensed to Glaxo, in the event of an influenza pandemic. The World Health Organization has identified Roche...